Table 1 Baseline characteristics of randomised controlled trials
Author, year of publication | Location | Baseline year of study | Population | Mean/median age (years) | % Males | Mean follow-up duration (years) | Implant design | Interventions evaluated | No. of participants/ joint replacements |
|---|---|---|---|---|---|---|---|---|---|
Partio, 1995 [38] | Finland | 1991–1992 | Osteoarthritis/Rheumatoid arthritis | 67.5 | 22.0 | 3.0 | Johnson & Johnson Press-fit condylar implant | Resurfacing/ No resurfacing | 95 |
Feller, 1996 [56] | Australia | 1990–1991 | Osteoarthritis (not otherwise specified) | 70.8 | 55.3 | 3.0 | Howmedica PCA Modular prosthesis | Resurfacing/ No resurfacing | 38 |
Kajino, 1997 [45] | Japan | NR | Rheumatoid arthritis | 56.1 | 7.7 | 6.6 | Yoshino-Shoji total knee prosthesis; Biomet, Warsaw, Indiana | Resurfacing/ No resurfacing | 52 |
Schroeder-Boersch, 1998 [35] | Germany | NR | Primary osteoarthritis | 72.6 | 30.0 | 2.0 | Howmedica Duracon | Resurfacing/ No resurfacing | 40 |
Newman, 2000 [19] | United Kingdom | 1992–1997 | Primary osteoarthritis | 71.9 | 32.8 | 5.0 | Howmedica PCA Modular prosthesis | Resurfacing/ No resurfacing/ Selective resurfacing | 105 |
Wood, 2002 [58] | Australia | 1992–1996 | Non-inflammatory arthritis | 73.7 | 52.7 | 4.0 | Zimmer Miller-Galante II | Resurfacing/ No resurfacing | 201 |
Mayman, 2003 [50] | Canada | 1991 | Osteoarthritis | 70.0 | 42.0 | 10.0 | Anatomic Medullary Knee, DePuy, Warsaw, IN | Resurfacing/ No resurfacing | 100 |
Waters, 2003 [37] | United Kingdom | 1992- | Osteoarthritis/inflammatory arthritis | 69.1 | 40.2 | 5.3 | Johnson & Johnson Press-fit condylar implant | Resurfacing/ No resurfacing | 390 |
Canada | 1991- | Osteoarthritis (not otherwise specified) | 70 | 43.3 | 10.0 | DePuy Anatomic Medullary Knee | Resurfacing/ No resurfacing | 83 | |
Gildone, 2005 [32] | Italy | 2002–2004 | Primary osteoarthritis | 74.1 | 30.4 | 2.1 | Zimmer Nexgen | Resurfacing/ No resurfacing | 56 |
Campbell, 2006 [55] | Australia | 1991–1993 | Primary osteoarthritis | 72.1 | 28.0 | 10.0 | Zimmer Miller-Galante II | Resurfacing/ No resurfacing | 100 |
Myles, 2006 [34] | United Kingdom | NR | Non-inflammatory arthritis | 70 | 52.0 | 1.8 | DePuy LCS rotating platform | Resurfacing/ No resurfacing | 50 |
Smith, 2008 [57] | Australia | 1998–2002 | Primary osteoarthritis | 71.5 | 50.4 | 4.0 | Smith & Nephew PROFIX | Resurfacing/ No resurfacing | 164 |
Burnett, 2009 [52] | USA | 1992–1993 | Degenerative osteoarthrosis | 66.2 | 79.1 | 10.0 | Zimmer Miller-Galante II | Resurfacing/ No resurfacing | 86 |
Beaupre, 2012 [53] | Canada | 1996–1999 | Non-inflammatory arthritis | 63.6 | 31.6 | 10.0 | Profix™ Total Knee System | Resurfacing/ No resurfacing | 38 |
Liu, 2012 [46] | China | 2000–2002 | Osteoarthritis | 67.7 | 62.9 | 7.0 | Press Fit Condylar, DePuy, Warsaw, IN | Resurfacing/ No resurfacing | 144 |
Ferguson, 2014 [33] (Fixed bearing) | United Kingdom | NR | Osteoarthritis (not otherwise specified) | 69.8 | 47.0 | 2.0 | PFC Sigma© Posterior Stabilised, DePuy, Warsaw, IN | Resurfacing/ No resurfacing | 176 |
Ferguson, 2014 [33] (Mobile Bearing) | United Kingdom | NR | Osteoarthritis (not otherwise specified) | 70.2 | 47.0 | 2.0 | PFC Sigma© Posterior Stabilised, DePuy, Warsaw, IN | Resurfacing/ No resurfacing | 176 |
Murray, 2014 [1] | United Kingdom | 1999–2003 | Osteoarthritis/Rheumatoid arthritis | 70 | 44.3 | 10.0 | NR | Resurfacing/ No resurfacing | 1715 |
Roberts, 2015 [54] | USA | 1996–2001 | Primary osteoarthritis | 70.7 | 48.6 | 7.8 | DePuy Sigma CR | Resurfacing/ No resurfacing | 114 |
Aunan, 2016 [30] | Norway | 2007–2011 | Primary osteoarthritis | 69.5 | 43.4 | 3.0 | Zimmer Nexgen | Resurfacing/ No resurfacing | 129 |
Ali, 2016 [29] | Sweden | 2008–2009 | Primary osteoarthritis | 68.5 | 39.2 | 6.0 | Triathlon CR | Resurfacing/ No resurfacing | 74 |
Vukadin, 2017 [36] | Serbia | NR | Osteoarthrosis/Valgus deformity | 67.4 | 45.0 | 2.0 | Zimmer Nexgen LPS-type | Resurfacing/ No resurfacing | 60 |
Dong, 2018 [47] | China | 2013–2015 | Late-stage osteoarthritis | 67.7 | 43.0 | 3.0 | Posterior cruciate stabilizing total knee prostheses | Resurfacing/ No resurfacing | 106 |
Jia, 2018 [43] | China | 2013–2015 | Bilateral knee osteoarthritis | 57.2 | 80.0 | 2.6 | NR | Resurfacing/ No resurfacing | 30 |
Kaseb, 2018 [40] | Iran | 2012–2013 | Non-inflammatory arthritis | 64.8 | 16.0 | 0.5 | Profix™ Total Knee System | Resurfacing/ No resurfacing | 50 |
Ha, 2019 [42] | China | 2011–2017 | Bilateral knee osteoarthritis | 65.2 | 63.3 | 5.5 | Stryker Scorpio NRG | Resurfacing/ No resurfacing | 120 |
Chawla, 2019 [49] | India | 2011–2013 | Osteoarthritis (not specified) | NR | 20.0 | 5.0 | NR | Resurfacing/ No resurfacing | 100 |
Kaseb, 2019 [41] | Iran | 2014–2017 | Primary osteoarthritis | 66.7 | 20.5 | 0.7 | Zimmer Nexgen | Resurfacing/ No resurfacing | 73 |
Thiengwittayaporn, 2019 [48] | Thailand | NR | Osteoarthritis (not otherwise specified) | 68.2 | 17.5 | 1.3 | Smith & Nephew Legion PS Total Knee System | Resurfacing/ No resurfacing | 84 |
Koh, 2019 [44] | Korea | 2012–2013 | Primary Osteoarthritis | 70.0 | NR | 5.0 | NR | Resurfacing/ No resurfacing | 98 |
van Raaij, 2021 [39] | Netherlands | 2012–2015 | Tricompartmental osteoarthritis | 69.5 | 38.1 | 2.0 | AGC Total Knee System, Biomet, Warsaw, IN | Resurfacing/ No resurfacing | 40 |
Deroche, 2022 [31] | France | 2017–2018 | Medial femorotibial osteoarthritis | 69.3 | 58.1 | 1.5 | Anatomic, AMPLITUDE®, Valence 26,000, FRANCE | Resurfacing/ No resurfacing | 250 |